Method of treating fibromyalgia with relaxin

• US 5,707,642 A
• Filed: 02/11/1997
• Issued: 01/13/1998
• Est. Priority Date: 11/17/1995
• Status: Expired due to Fees

• Current Assignee: SKY Bioheath Solutions, Inc.
• Original Assignee: Samuel K. Yue
• Inventors: Yue, Samuel K.
• Primary Examiner(s): AZPURU, CARLOS A
• Application Number:
  US08/802,340
• Time in Patent Office: 336 Days
• Field of Search: 424/423, 424/443, 424/449, 424/464, 514/12, 530/324
• US Class Current: 424/423
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/565 not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
• CPC Class Codes: A61K 31/57 substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
• CPC Class Codes: A61K 38/22 Hormones derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin A61K38/33, e.g. corticotropin A61K38/35
• CPC Class Codes: A61K 38/2221 Relaxins

Abstract

A method of treating involuntary muscle dysfunctions includes administering a therapeuticaly effective amount of relaxin to a patient. Involuntary muscle dysfunctions amenable to treatment with relaxin include fibromyalgia, myofascial pain syndrome, chronic fatigue syndrome, dystonia, pelvic floor dysfunction, irritable bowel syndrome, and others.

Claims

1. A method for treating fibromyalgia by administering to a patient exhibiting painful contraction of bodily muscles from fibromyalgia a therapeutically effective amount of relaxin hormone, thereby decreasing the amount of painful contraction of the bodily muscles affected by relaxin.